| ESVIM – European Society of Veterinary Internal Medicine |
| Thursday 14 September |
| 09.00-09.15 |
ESVIM-O-1 |
Cuq |
Calibrated automated thrombography to evaluate thrombin generation in dogs with immune-mediated hemolytic anaemia |
| 09.15-09.30 |
ESVIM-O-2 |
Dandrieux |
Effect of immune-suppressive treatment on cytokine production in healthy dogs |
| 09.30-09.45 |
ESVIM-O-3 |
Hansson-Hamlin |
Identification of antinuclear antibodies in dogs using immunodiffusion |
| Friday 15 September |
| 14.40-14.55 |
ESVIM-O-4 |
Brown |
Short- and long-term morbidity and mortality in dogs and cats following cardiopulmonary arrest |
| 14.55-15.10 |
ESVIM-O-6 |
Darcy |
Feline primary erythrocytosis: a multicentre retrospective case series (18 cases) |
| 15.10-15.25 |
ESVIM-O-7 |
Roels |
Investigation of a fungal aetiology in canine idiopathic pulmonary fibrosis |
| 15.25-15.40 |
ESVIM-O-8 |
Keegan |
Clinical features of 70 cases of canine idiopathic eosinophilic lung disease |
| 15.40-15.55 |
ESVIM-O-9 |
Keegan |
Therapy and long-term follow-up of 70 cases of canine idiopathic eosinophilic lung disease |
| 16.30-16.45 |
ESVIM-O-10 |
Vientos-Plotts |
Development of respiratory dysbiosis as cats transition from healthy to asthmatic airways |
| 16.45-17.00 |
ESVIM-O-11 |
Grobman |
Documenting silent reflux and microaspiration events using nuclear scintigraphy in healthy dogs |
| 17.00-17.15 |
ESVIM-O-12 |
Canonne |
Diagnosis of pulmonary angiostrongylosis in dogs with negative non-invasive tests (Baermann analysis and AngioDetectTM©) |
| 17.15-17.30 |
ESVIM-O-13 |
Grobman |
Discrimination between cough and non-cough behaviours using acoustic wave recordings |
| 17.30-17.45 |
ESVIM-O-14 |
Robin |
Tracheal stent in dogs: outcome prediction and owner satisfaction assessment |
| 17.45-18.00 |
ESVIM-O-15 |
Stengel |
Meticulous debridement as sole management for successful outcome in 6 dogs with sinonasal aspergillosis (SNA) |
| ESVC – European Society of Veterinary Cardiology |
| Thursday 14 September |
| 14.25-14.40 |
ESVC-O-1 |
Vitt |
Utility of VHS to predict echocardiographic EPIC Trial inclusion criteria in dogs with myxomatous mitral valve disease: A retrospective multicentre study |
| 14.40-14.55 |
ESVC-O-2 |
Rocchi |
Evaluation of continuous positive airway pressure in dogs with cardiogenic pulmonary oedema secondary to severe mitral valve disease |
| 14.55-15.10 |
ESVC-O-3 |
Rishniw |
Development of a simple algorithm for diagnosis of left-sided congestive heart failure in dogs with mitral valve disease |
| 15.10-15.25 |
ESVC-O-4 |
Lee |
Effects of treatment with thromboxane A2 synthase inhibitor on pulmonary hypertension: a pilot study |
| 15.25-15.40 |
ESVC-O-5 |
Vezzosi |
Echocardiographic evaluation of right ventricular dimension and systolic function in dogs with pulmonary hypertension |
| 15.40-15.55 |
ESVC-O-6 |
Merveille |
Caudal vena cava assessment in dogs with right-sided congestive heart failure: a pilot study |
| 15.55-16.10 |
ESVC-O-7 |
Blake |
Heart rate variability in dogs with intracranial disease |
| 16.10-16.25 |
ESVC-O-8 |
Kiss |
Genetic background of focal junctional tachycardia with isorhythmic atrioventricular dissociation in Labrador retrievers |
| 16.25-16.40 |
ESVC-O-9 |
Oxford |
Immunofluorescent localization of plakoglobin in endomyocardial biopsy samples to diagnose arrhythmogenic right ventricular cardiomyopathy (ARVC) in the dog |
| Friday 15 September |
| 08.00-08.15 |
ESVC-O-10 |
LeBlanc |
Right ventricular volume quantification measured by real-time 3D echocardiography and ECG-gated 64 slice MDCT in healthy dogs |
| 08.15-08.30 |
ESVC-O-11 |
Damoiseaux |
Feasibility of intracardiac echocardiography in dogs: a pilot study |
| 08.30-08.45 |
ESVC-O-12 |
Corda |
Use of two-dimensional speckle tracking echocardiography to assess left ventricular systolic function in dogs with systemic inflammatory response syndrome |
| 08.45-09.00 |
ESVC-O-13 |
Bree |
Major histocompatibility complex class II haplotypes associated with remodelling in Cavalier King Charles spaniels with chronic valvular heart disease |
11.20-11.35
|
ESVC-O-14 |
Traub |
MiRNAs in progressing canine myxomatous mitral valve disease |
| 11.35-11.50 |
ESVC-O-15 |
Tims |
White coat effect in client-owned dogs, as assessed by high definition oscillometry (HDO) |
| 11.50-12.05 |
ESVC-O-16 |
Mckeever |
Prevalence and murmur characteristics of incidentally detected heart murmurs and heart disease in 12,958 young healthy shelter cats |
12.05-12.20
|
ESVC-O-17 |
Szatmári |
When should we talk about tachypnoea in cats at the veterinarian’s consultation room? |
| 12.20-12.35 |
ESVC-O-18 |
Szatmári |
How often do primary care practitioners recognise innocent cardiac murmurs in puppies during the first veterinary health check? |
| 12.35-12.50 |
ESVC-O-19 |
Connolly |
Towards cardiac stem cell therapy: characterisation and cryopreservation of canine cardiosphere-derived cells |
| 16.45-17.00 |
ESVC-O-20 |
Dutton |
Assessing the feasibility of allogeneic stem cell therapy for canine dilated cardiomyopathy |
| 17.00-17.15 |
ESVC-O-21 |
Ohad |
The association of clinical, laboratory and echocardiographic findings with survival in 108 dogs undergoing pericardiocentesis; a retrospective study |
17.15-17.30
|
ESVC-O-22 |
Neves |
Usefulness of colour TDI at the level of lateral atrial tissue as a predictor of future development of atrial fibrillation in dogs |
| 17.30-17.45 |
ESVC-O-23 |
Beijerink |
ECG-gated computed tomography angiography of patent ductus arteriosus in 25 dogs |
| 17.45-18.00 |
ESVC-O-24 |
Szatmári |
Is prophylactic antibiotic therapy necessary to prevent infectious endocarditis in dogs that undergo transcatheter embolisation of a patent ductus arteriosus? |
| Saturday 16 September |
16.30-16.45
|
ESVC-O-25 |
Gomart |
Biological variability of N-terminal pro-B-type natriuretic peptide in fifty-three healthy Labrador retrievers over an 8 month period |
| 16.45-17.00 |
ESVC-O-26 |
Glen |
Clinical use of a patient-side feline NT-proBNP ELISA test in 281 cats in general practice |
| 17.00-17.15 |
ESVC-O-27 |
Romito |
Diagnostic and prognostic utility of surface ECG in cats with left ventricular hypertrophy |
| 17.15-17.30 |
ESVC-O-28 |
Winter |
Notched QRS complexes in dogs with and without structural cardiac disease: 85 cases |
| ESVNU – European Society of Veterinary Nephrology and Urology |
| Thursday 14 September |
| 14.25-14.40 |
ESVNU-O-1 |
Sargent |
Fibroblast growth factor 23 and symmetric dimethylarginine in feline chronic kidney disease |
| 14.40-14.55 |
ESVNU-O-2 |
van den Broek |
Immunohistochemical staining of a-klotho protein in feline kidney tissue |
| 14.55-15.10 |
ESVNU-O-3 |
Pelander |
Symmetric dimethylarginine (SDMA) compared to creatinine for detection of decreased GFR in 97 dogs with stable kidney function |
| 15.10-15.25 |
ESVNU-O-4 |
Buresova |
SDMA in hyperthyroid cats before and after treatment with radioiodine |
| 15.25-15.40 |
ESVNU-O-5 |
Chen |
Interleukin 6 and Interleukin 18 as markers of kidney injury in dogs |
| 15.40-15.55 |
ESVNU-O-6 |
Segev |
Application of novel kidney-specific biomarkers for canine kidney diseases |
| 15.55-16.10 |
ESVNU-O-7 |
Lamoureux |
Prevalence of urinary tract infection in dogs with chronic kidney disease: a retrospective study of 201 cases |
| 16.10-16.25 |
ESVNU-O-8 |
Johnstone |
Whole genome sequencing of Escherichia coli isolated from the urinary tract of individual dogs over time |
| 16.25-16.40 |
ESVNU-O-9 |
Pomba |
Virulence and antimicrobial resistance of Escherichia coli Sequence Type 131 H30 and other human pandemic clones spreading in companion animals |
| Saturday 16 September |
| 14.25-14.40 |
ESVNU-O-10 |
Russak |
Urinary biomarker concentrations in canine urinary tract infections |
| 14.40-14.55 |
ESVNU-O-11 |
Garcia |
Evolution of ionised calcium concentration over time in cats with ureteral obstruction: 39 cases |
| 14.55-15.10 |
ESVNU-O-12 |
Crisi |
Urinary findings suggesting early renal involvement in cats with Feline Morbillivirus infection |
| 15.10-15.25 |
ESVNU-O-13 |
Reynolds |
Effects of a non-absorbent litter on urinalysis results in cats |
| 15.25-15.40 |
ESVNU-O-14 |
Garcia |
Determining the pH in canine urine: comparing visual and automated reading variability of urine dipstick analysis within a small animal teaching hospital |
| 15.40-15.55 |
ESVNU-O-15 |
van den Berg |
Assessment of kidney injury in canine parvoviral infection by comparing novel urinary kidney injury biomarkers with routine renal functional parameters |
| ESVONC – European Society of Veterinary Oncology |
| Friday 15 September |
| 09.30-09.45 |
ESVONC-O-1 |
Zandvliet |
Are protein kinase inhibitors of use in the treatment of canine lymphoma? A screening in vitro study with multiple protein kinase inhibitors in canine lymphoid cell lines |
| 09.45-10.00 |
ESVONC-O-2 |
Giuliano |
Masitinib treatment for advanced stage III and IV canine melanoma |
| 10.00-10.15 |
ESVONC-O-3 |
Elliott |
Toceranib phosphate in fifteen dogs with stage 4 anal sac apocrine gland adenocarcinoma |
| 10.15-10.30 |
ESVONC-O-4 |
Lyons |
Effect of toceranib phosphate (Palladia®) on outcome in dogs with anal sac carcinoma |
11.20-11.35
|
ESVONC-O-5 |
Børresen |
The occurrence of feline neoplasia; a comparison between Danish and North American cats |
| 11.35-11.50 |
ESVONC-O-6 |
Aghazadeh |
Expression of Felis catus gammaherpesvirus-1 ORF73, F7 and ORF50 in FIV-associated lymphoma biopsies |
| 11.50-12.05 |
ESVONC-O-7 |
Boye |
High pretreatment D-dimer concentraion is associated with poor prognosis in 48 dogs with high-grade lymphoma |
12.05-12.20
|
ESVONC-O-8 |
Treggiari |
Efficacy of chemotherapy and clinical outcome in primary, metastatic feline pulmonary carcinomas: an observational study |
| 12.20-12.35 |
ESVONC-O-9 |
Aupperle-Lellbach |
Ovarian tumours in the bitch – Pathological findings and AMH values |
| 12.35-12.50 |
ESVONC-O-10 |
Bechtel |
Initial evaluation of gum arabic coated radioactive gold nanoparticles in canine prostatic cancer |
| SCH – Society of Comparative Hepatology |
| Friday 15 September |
| 08.00-08.15 |
SCH-O-1 |
Bayton |
Prednisolone therapy for chronic hepatitis in the English Springer Spaniel: A prospective study of 14 cases |
| 08.15-08.30 |
SCH-O-2 |
Ullal |
Ciclosporin in the treatment of canine chronic hepatitis |
| 08.30-08.45 |
SCH-O-3 |
Kortum |
Investigation into hepatocyte expression and prognostic significance of senescence marker p21 in canine chronic hepatitis |
| 08.45-09.00 |
SCH-O-4 |
Sato |
Chronic portal vein thrombosis in eleven dogs |
| 09.00-09.15 |
SCH-O-5 |
Allerton |
Breed predisposition to gall bladder mucocoeles in Border Terriers |
| 09.15-09.30 |
SCH-O-6 |
Valiente |
Outcome of cats undergoing surgical attenuation of congenital extrahepatic portosystemic shunts through cellophane banding: 23 cases |
| 09.30-09.45 |
SCH-O-7 |
Neiger |
Transcutaneous fluorometric measurement of indocyanine green clearance as dynamic liver function test in dogs with congenital portosystemic shunt |
| ESCG – European Society of Comparative Gastroenterology |
| Friday 15 September |
| 09.45-10.00 |
ESCG-O-1 |
Heilmann |
Serum S100/calgranulin concentrations in Miniature Schnauzers with idiopathic hyperlipidemia |
| 10.00-10.15 |
ESCG-O-2 |
Williams |
Serum tocopherol and retinol concentrations in dogs with exocrine pancreatic insufficiency |
| 10.15-10.30 |
ESCG-O-3 |
Schleifenbaum |
Effect of mirtazapine on canine gastric emptying assessed by 13C-sodium acetate breath test (13C-SABT) |
| 11-20-11.35 |
ESCG-O-4 |
Botha |
Prevalence of Clostridium difficile and Salmonella spp. in Juvenile Dogs Affected with Parvoviral Enteritis |
| 11.35-11.50 |
ESCG-O-5 |
Albuquerque |
Risk factors for C. difficile carriage in dogs and associations with clinical disease |
| 11.50-12.05 |
ESCG-O-6 |
Manchester |
Long-term impact of tylosin on the faecal microbiota of healthy dogs |
| 12.05-12.20 |
ESCG-O-7 |
Cartwright |
Vitamin D receptor expression in the dog and the effect of intestinal inflammation |
| 12.20-12.35 |
ESCG-O-8 |
Konstantinidis |
Serum circulating microRNAs as a marker for canine lymphocytic- plasmacytic inflammatory bowel disease |
| 12.35-12.50 |
ESCG-O-9 |
Allenspach |
Specific virulence factors in mucosa-associated E. coli of dogs with inflammatory bowel disease (IBD) are associated with survival |
| Saturday 16 September |
| 16.30-16.45 |
ESCG-O-10 |
Coddou |
Identification of IgG4-related disease in the English Cocker Spaniel and dogs of other breeds |
| 16.45-17.00 |
ESCG-O-11 |
Allenspach |
Correlating gastrointestinal histopathologic findings to clinical disease activity in dogs with inflammatory bowel disease |
| 17.00-17.15 |
ESCG-O-12 |
Freiche |
Acquired oesophageal strictures: balloon dilatation or stenting? Outcome and complications in 24 dogs and cats (2002-2017) |
| 17.15-17.30 |
ESCG-O-13 |
Dominguez Ruiz |
Prevalence of gastric lymphoid follicular hyperplasia in French Bulldogs |
| 17.30-17.45 |
ESCG-O-14 |
Woolhead |
A retrospective evaluation of ileocecocolic perforations associated with routine diagnostic lower gastrointestinal endoscopy in dogs and cats |
| 17.45-18.00 |
ESCG-O-15 |
Da Riz |
Acquired pyloric stenosis in cats: a prospective study of 15 cats (2015-2017) |
| ESVE – European Society of Veterinary Endocrinology |
| Saturday 16 September |
| 08.15-08.30 |
ESVE-O-1 |
Sieber-Ruckstuhl |
Agreement of two prepill cortisol measurements in dogs with hypercortisolism treated with trilostane |
| 08.30-08.45 |
ESVE-O-2 |
van Staalduinen |
Sterol-O-acyl transferase 1 (SOAT1) expression in canine cortisol-secreting adrenocortical tumours: providing the basis for a future treatment option |
| 08.45-09.00 |
ESVE-O-3 |
de Wit |
CYP17 inhibitor abiraterone acetate as a promising future treatment for canine hyperadenocorticism: in vitro investigations |
| 14.25-14.40 |
ESVE-O-4 |
Sanders |
Molecular prognostic markers in canine cortisol-secreting adrenocortical tumours |
| 14.40-14.55 |
ESVE-O-5 |
Hanson |
The use of chromogranin A epitopes vasostatin and catestatin as biomarkers for catecholamine-producing tumours in dogs |
| 14.55-15.10 |
ESVE-O-6 |
Scudder |
Pilot study assessing the use of cabergoline in the management of diabetic acromegalic cats |
| 15.10-15.25 |
ESVE-O-7 |
Woolhead |
Serial changes in insulin-like growth factor 1 and impact on hypersomatotropism-screening in feline diabetes mellitus |
| 15.25-15.40 |
ESVE-O-8 |
Zini |
Ultrastructural characterisation of pancreatic beta-cells in cats with diabetes mellitus |
| 15.40-15.55 |
ESVE-O-9 |
Niessen |
The diabetic clinical score (DCS): evaluation of a simple standardised quantification tool to allow rapid description of clinical signs in diabetic dogs |
| 16.30-16.45 |
ESVE-O-10 |
Finch |
Thyroid and renal function in cats post low-dose radioiodine therapy |
| 16.45-17.00 |
ESVE-O-11 |
Casado Diaz |
Evaluation of symmetric dimethylarginine (SDMA) in dogs with primary hypoadrenocorticism under long-term mineralocorticoid replacement therapy |
| 17.00-17.15 |
ESVE-O-12 |
Spence |
A comparison of the ACTH concentrations in dogs with stable hypoadrenocorticism being treated with either fludrocortisone or desoxycortone pivalate and prednisolone |
| 17.15-17.30 |
ESVE-O-13 |
Hagblom |
Prevalence of hyperaldosteronism and hypertension in cats with chronic azotaemia |
| 17.30-17.45 |
ESVE-O-14 |
Pijnacker |
The use of a TRH stimulation test, with measurement of plasma concentrations of growth hormone and thyroid stimulating hormone, to differentiate between primary hypothyroidism and non-thyroidal illness in dogs |
| 17.45-18.00 |
ESVE-O-15 |
Scarpa |
Interrelation between thyroid function and sex hormones in female German Shepherd Dogs |
| ESVCN – European Society of Veterinary Comparative Nutrition |
| Saturday 16 September |
| 08.15-08.30 |
ESVCN-O-1 |
Söder |
Plasma metabolomics reveals lowered carnitine concentrations in overweight Labrador retriever dogs |
| 08.30-08.45 |
ESVCN-O-2 |
Kiefer-Hecker |
Silica urolithiasis in a dog - a case report |
| 08.45-09.00 |
ESVCN-O-3 |
Dobenecker |
Knowing the total amount of phosphorus in a diet is not enough – different sources have different effects |
| ESVCP – European Society of Veterinary Clinical Pathology |
| Saturday 16 September |
| 09.15-09.30 |
ESVCP-O-1 |
Aroch |
Pre- and post-operative D-dimer concentration in dogs changes in D-dimer concentration in dogs following soft tissue and orthopaedic surgery |
| 09.30-09.45 |
ESVCP-O-2 |
Whitehead |
Evaluation of haemostatic changes in dogs with parvoviral enteritis before and after fluid resuscitation using thromboelastography |
| 09.45-10.00 |
ESVCP-O-3 |
König |
Analytical and clinical validation of a human enzyme-linked immunosorbent assay (ELISA) for measurement of canine angiopoietin-2 |
| 10.00-10.15 |
ESVCP-O-4 |
König |
Plasma angiopoietin-2 (Ang-2) is elevated in dogs with sepsis and/or systemic inflammatory disease syndrome (SIRS) and is associated with severity of disease and outcome |
| 10.15-10.30 |
ESVCP-O-5 |
Neumann |
Investigation of Interleukin-6 (IL-6) as prognostic marker |
| 11.20-11.35 |
ESVCP-O-6 |
Leynaud |
Comparison of serum amyloid A and fibrinogen to other inflammatory biomarkers in cats |
| 11.35-11.50 |
ESVCP-O-7 |
Bremer |
Identification of ILF2 autoantibodies as a promising biomarker for autoimmune disease in dogs |
| 11.50-12.05 |
ESVCP-O-8 |
Aroch |
Serum histones as biomarkers of the severity of heatstroke in dogs |
| 12.05-12.20 |
ESVCP-O-9 |
Zoia |
Pleural effusion lactate dehydrogenase (LDHp) concentration and serum total protein (TPs) concentration versus traditional veterinary classification method in the discrimination between transudates and exudates: a cross-sectional study in 100 dogs with pleural effusion |
| 12.20-12.35 |
ESVCP-O-10 |
Burchell |
The site of bone marrow acquisition affects the myeloid to erythroid ratio in apparently healthy dogs |
| 12.35-12.50 |
ESVCP-O-11 |
Cuq |
Acute myeloid leukemia in retrovirus-negative cats: a case series of 16 patients |
| ISCAID - International Society for Companion Animal Infectious Diseases |
| Saturday 16 September |
| 11.20-11.35 |
ISCAID-O-1 |
Barrs |
Re-emergence of feline panleukopenia in Australia |
| 11.35-11.50 |
ISCAID-O-2 |
Byrne |
Investigation of faecal parvovirus shedding in asymptomatic shelter housed cats in Australia |
| 11.50-12.05 |
ISCAID-O-3 |
Ferri |
Class A CpG oligonucleotides in cats with naturally occurring feline panleukopenia infection: a prospective case-control study |
| 12.05-12.20 |
ISCAID-O-4 |
Barrs |
Feral carnivores are reservoirs of Carnivore protoparvovirus 1 in Australia |
| 12.20-12.35 |
ISCAID-O-5 |
de Luca |
Feline morbillivirus infection in domestic cats in Italy: epidemiological and pathological aspects |
| 12.35-12.50 |
ISCAID-O-6 |
Felten |
Evaluation of a discriminative realtime RT-PCR in cerebrospinal fluid for the diagnosis of feline infectious peritonitis |
| 14.25-14.40 |
ISCAID-O-7 |
Duplan |
Screening for selected pathogens in ticks infecting cats in the United Kingdom: a large-scale surveillance programme |
| 14.40-14.55 |
ISCAID-O-8 |
Dvir |
The role of hypovitaminosis d in complicated canine babesiosis |
| 14.55-15.10 |
ISCAID-O-9 |
Barash |
Is urine culture the poor man’s blood culture? Concordance between parallel canine blood and urine cultures |
| 15.10-15.25 |
ISCAID-O-10 |
Pomba |
Companion animals and humans with UTI share common uropathogenic Klebsiella pneumoniae |
| 15.25-15.40 |
ISCAID-O-11 |
Leutenegger |
Validation of a qPCR panel to aid in the diagnosis of dermatophytosis |
| VBPS - Veterinary Blood Pressure Society |
| 16.30-16.45 |
VBPS-O-1 |
Glaus |
Efficacy of telmisartan in hypertensive cats: results of a large European clinical trial |
